Sandoz Group

Update in progress

SDZ.SW (Swiss)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Sandoz Group AG develops, manufactures, and markets generic medicines and biosimilars worldwide. It serves therapeutic areas including cardiovascular, central nervous system, oncology, infectious diseases, pain, respiratory, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, ophthalmology, and supportive care. The company also supplies active pharmaceutical ingredients and finished dosage forms. Founded in 1886, it is headquartered in Basel, Switzerland.

Company score

Sentiment: -0.14; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.01; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.04; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.01; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.07; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketSwiss (EBS)
LocationSwitzerland
Founded1886
Employees20,000
Websitewww.sandoz.com

Identifiers

ISINCH1243598427
FIGIBBG01J3DD3T3